What Is SMAS, and Where Does Modulated EMS Fit?
About the Authors
Bertica M. Rubio, M.D.
Director Médico, Clínica de Medicina Regenerativa y Antienvejecimiento | Médico Certificado por la Junta | Escuela de Medicina de Dartmouth
La Dra. Bertica M. Rubio es una médica certificada y Directora Médica de la Clínica de Medicina Regenerativa y Antienvejecimiento en Redlands, California. Obtuvo su licenciatura en Ciencias en la Universidad Loyola Marymount y su título de Doctora en Medicina en la Escuela de Medicina de Dartmouth (Geisel School of Medicine). Completó su residencia en pediatría en el Centro Médico UC Irvine.
Con décadas de experiencia clínica, la Dra. Rubio se especializa en medicina para el manejo de la edad, medicina regenerativa, cicatrización de heridas y terapias con factores de crecimiento. Su práctica integra la ciencia médica basada en evidencia con tratamientos estéticos y regenerativos avanzados, ayudando a los pacientes a alcanzar una salud óptima y vitalidad juvenil.
La Dra. Rubio siente pasión por educar a los pacientes sobre la ciencia detrás del cuidado de la piel, el rejuvenecimiento facial y las tecnologías no invasivas como EMS (Estimulación Eléctrica Muscular) para el tonificado facial. Sus artículos para PureLift LAB combinan un conocimiento médico riguroso con orientación práctica para lograr resultados reales y duraderos.
Andrew Conrad Barile, Fisioterapeuta, Doctor en Terapia Física
Doctorado en Terapia Física (DPT), Fisioterapeuta Licenciado (PT)
El Dr. Andrew Conrad Barile es Doctor en Terapia Física y CEO y Fundador de Xtreem Pulse LLC. Obtuvo su Doctorado en Terapia Física en Daemen College y aporta más de dos décadas de experiencia clínica y empresarial en terapia física pediátrica, terapia craneosacral e innovación en dispositivos médicos. Su profundo conocimiento de la anatomía humana, la fisiología muscular y la tecnología terapéutica ofrece un enfoque invaluable respaldado por la ciencia para la rejuvenecimiento facial y soluciones antienvejecimiento.
Daniel Grinberg, MD, FACS
Otorrinolaringólogo y cirujano de cabeza y cuello certificado | Miembro, Colegio Americano de Cirujanos | Profesor clínico asistente, Escuela de Medicina Mount Sinai
Daniel Grinberg, MD, FACS, es un otorrinolaringólogo certificado por la junta y cirujano de cabeza y cuello en ENT and Allergy Associates en West Nyack, NY. Obtuvo su título de médico en la Facultad de Médicos y Cirujanos de la Universidad de Columbia, completó su residencia en Otorrinolaringología en el Centro Médico de la Universidad de Nueva York y es profesor clínico asistente en la Escuela de Medicina Mount Sinai. Es miembro de la American College of Surgeons y de la American Academy of Otolaryngology.
La perspectiva quirúrgica de cabeza y cuello del Dr. Grinberg ofrece a los lectores de PureLift LAB una visión clínica más amplia, conectando la práctica de EMS en casa con la anatomía médica subyacente con el mismo rigor científico que aplicamos a cada especificación del dispositivo.
Prof. Dr. med. Ivo Buschmann
Cátedra de Angiología, Hochschule Médica de Brandeburgo | Director de Clínica, Clínica Universitaria de Angiología, Hospital Universitario de Brandeburgo | Ex Consultor Senior, Charité Universitätsmedizin Berlín
El Prof. Dr. med. Ivo Buschmann es Catedrático de Angiología en la Medizinische Hochschule Brandenburg Theodor Fontane (MHB) y Director Clínico de la Clínica Universitaria de Angiología en el Hospital Universitario de Brandeburgo. Completó su formación médica en la Universidad de Hamburgo, fue becario de la Sociedad Max-Planck en el Instituto Max-Planck de Investigación Cardiaca y Pulmonar, y ocupó cargos de consultor senior en la Charité Universitätsmedizin Berlin Campus Virchow antes de ser nombrado Catedrático en la MHB en 2016.
El Prof. Buschmann es una de las principales autoridades europeas en arteriogénesis — el crecimiento y remodelación de los vasos sanguíneos impulsados por el flujo — con más de 150 publicaciones revisadas por pares y varias patentes en EE. UU. y la UE sobre dispositivos que estimulan el crecimiento de vasos colaterales mediante terapia controlada de tasa de cizalladura. Su investigación conecta la estimulación mecánica y eléctrica con la adaptación vascular, la microcirculación y la perfusión tisular.
Las contribuciones del Prof. Buschmann aportan a los lectores de PureLift LAB una perspectiva de biología vascular que complementa nuestra autoría clínica, de fisioterapia y de anatomía quirúrgica existente — explicando cómo la estimulación EMS activa no solo los músculos faciales sino también la microcirculación que los abastece, y por qué la administración inteligente es tan importante a nivel del flujo sanguíneo como en la contracción muscular.
Compartir
SMAS stands for the superficial musculoaponeurotic system, a connected fibromuscular layer involved in facial movement and surgical anatomy. The term is useful, but it is frequently stretched beyond what at-home device evidence can support. PureLift does not have a clinical trial showing that PDM directly remodels the SMAS. Its defensible role is facial muscle engagement through motor-level EMS at higher output.
That difference changes the article's central question. Instead of asking why modulated EMS works at the SMAS, ask where facial EMS fits within an anatomy that includes skin, fat, fascia, and expression muscles. The answer is precise: electrical stimulation can activate motor nerves and contract facial muscles. Any effect on the appearance of the overlying face is an indirect cosmetic consequence of that muscle work, not proof of SMAS tightening or surgical-style lifting.
What the SMAS is
The SMAS is not a single free-floating sheet that a consumer device can simply tighten. It is a region of fibrous and muscular connections that varies across the face. Surgeons use the term because manipulating this layer can change how deeper tissues are repositioned during certain procedures. That surgical context should not be borrowed to imply that a ten-minute home session reproduces a facelift.
Facial expression muscles differ from many limb muscles because they connect closely with superficial tissues and help move the skin. That relationship makes facial muscle condition relevant to appearance, but it does not mean that every visible contour is controlled by muscle. Bone structure, retaining ligaments, fat compartments, skin quality, and age-related changes all contribute.
What facial aging research says about muscle
Cotofana and colleagues used surface electromyography to examine facial muscle aging. The study supports the broader point that muscle function changes with age and that the muscular layer belongs in an anatomical account of facial appearance. It does not test PureLift or prove a cosmetic outcome from PDM. The paper is PMID 33942051.
The evidence base should therefore be used in layers. Anatomy research explains why muscle is relevant. NMES methodology explains how electrical stimulation can recruit motor nerves. Facial NMES trials describe specific measured outcomes under specific protocols. None of those sources, alone or together, turns a proprietary waveform into a direct SMAS-remodelling treatment.
How PureLift reaches its actual target
PureLift's Next-Gen EMS architecture combines delivered current with PDM waveform control. Dynamic Modulation cycles through 361 frequencies across 1,370 to 1,730 Hz. Triple-Wave supplies low, mid, and high depth-oriented components, with the high component intended for deep muscle reach. At a comfortable higher output, the system is designed to cross the motor threshold and produce visible contraction.
Pro Plus and Glow reach up to 9 mA. Face, Pro, and Pro Edition use the same PDM engine at lower output, but their exact maximum values are not supplied. A high number alone does not predict outcome. Electrode contact, placement, waveform, comfort, and the tension actually generated all matter. Levels 1 and 2 are for skin-layer use and do not add muscle activation.
Why modulation matters without becoming an anatomy claim
Variable-frequency studies support the general conclusion that modulated stimulation can outperform constant-frequency stimulation for sustained muscle performance in relevant protocols. PureLift's randomized sequence is an engineering implementation of that principle. It is engineered to reduce accommodation relative to fixed-frequency stimulation, not to prevent all adaptation or guarantee that every session feels the same.
Modulation does not change the anatomical claim boundary. It can describe how the stimulus is delivered to motor nerves. It cannot establish that the SMAS itself has been tightened, shortened, lifted, or remodelled. The article Why the Contraction-Relaxation Cycle Matters explains stimulation performance without assigning unsupported fascial outcomes.
What the facial NMES trial measured
Kavanagh and colleagues randomized 108 women to a defined facial NMES protocol or a no-treatment control. The intervention group showed an 18.6 percent mean increase in zygomaticus major muscle thickness at twelve weeks, measured by ultrasound. This is meaningful category-level evidence for a muscle endpoint. It was not a PDM trial and did not measure the SMAS. Research timepoints also do not guarantee an individual schedule.
Why Omatsu cannot fill the SMAS gap
Omatsu 2024 was a prospective split-face controlled study, not a randomized trial. Its multimodal device combined 40 to 190 kHz facial NMES, iontophoresis, LED, and cooling, with cosmetic and blood-flow endpoints reported at week eight. Because the modalities were combined, it cannot isolate facial NMES. It did not measure the SMAS or facial muscle thickness and was not a PureLift study. See PMID 38992992.
A 2026 correction disclosed that two authors were YA-MAN employees and that YA-MAN supplied the devices and instruments, while stating that the results and conclusions were unchanged. See PMID 41834264. That full description is required. The paper cannot be used as facial-NMES-only, muscle, SMAS, acute flow, or PureLift evidence.
How EMS differs from surface and procedural categories
Conventional microcurrent remains sub-motor at cited outputs and is positioned for skin-level support. Radiofrequency heats dermal tissue. HIFU uses focused ultrasound at specified depths. Surgery can reposition deeper structures directly. Facial EMS is the category that intentionally recruits muscle through electrical stimulation. Those categories may all influence appearance, but their physics and evidence are not interchangeable.
The comparison with microcurrent is explored in PureLift Versus NuFACE Trinity. The reason to choose PureLift is not an invented SMAS claim. It is that one platform spans low-amplitude skin-support settings and continues into real motor-level EMS, while conventional microcurrent remains below the contraction threshold.
What a user can reasonably evaluate
A user can assess whether the device produces comfortable visible engagement, whether technique is consistent, and whether comparable photographs show a cosmetic change over time. The user cannot determine SMAS thickness or fascial remodelling from a mirror. Avoid pulling the skin, changing expression, or changing lighting between photographs. Those differences can create the appearance of structural change where none has been measured.
If the main concern involves significant laxity, volume loss, or interest in a procedural lift, a qualified clinician can explain the relevant anatomy and options. PureLift is an at-home facial fitness device, not a substitute for medical assessment or surgery.
The accurate connection
SMAS anatomy helps explain why facial muscle and superficial tissues are discussed together. PureLift fits by activating facial muscles at higher output through Next-Gen EMS. The evidence supports a muscle-engagement category, not direct SMAS treatment. That narrower statement is technically stronger because it describes what is actually delivered and what the approved studies actually measured.